Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Emplicure Pharma AB
AB
Active
Org 5593971608
Libro Ringväg 29 B, 752 28
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 3 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Emplicure Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
-1M
-2M
-3M
-4M
0M
2023
-3M
-300%
2024
0M
+100%
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
0
—
0
Staff expenses
—
−110
−0
EBITDA
−43
−2 972
−245
Depreciation & amort.
−0
—
—
EBIT
−43
−2 972
−245
Net financials
—
3
8
Profit before tax
0
−2 969
−237
Tax
−0
—
—
Net profit
0
−2 969
−237
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
41
894
828
Equity
25
435
198
Long-term debt
0
—
—
Short-term debt
16
459
630
Total debt
16
459
630
Financial ratios
5-year trend
EBITDA margin
-24468400.0%
This company
15.8%
Market median
-154863391% vs market
2023
2025
Equity ratio
23.9%
This company
38.2%
Market median
-37% vs market
2023
2025
Return on equity
-119.6%
This company
18.4%
Market median
-750% vs market
2023
2025
Net profit margin
-23686100.0%
This company
8.1%
Market median
-292421088% vs market
2023
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2025
Debt / equity
3.18×
This company
0.62×
Market median
-413% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-12-31
View
PDF
More on Emplicure Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
